September 2020 – Santec merger with International Farmacéutica S. A.
Santec Medicalprodukte GmbH has been known for many years as a specialist in the field of cardiovascular surgery. Due to the increasing requirements in the regulatory area, new financial challenges are consistently arising, which Santec would like to compensate for by increasing international sales activities, among other things.
During this process, numerous contacts to suture material distributors/manufacturers worldwide have been established already in order to promote internationalization – among others with Atramat from Mexico, who are also looking to expand their sales activities in the area of “general surgical sutures” to Europe and especially Germany.
After various discussions and considering the aspect of the age-related succession issue at the shareholder level of Santec, a takeover by International Farmacéutica, S. A. in Mexico, with the brand name “Atramat®“, was agreed upon as of 01.01.2020. Atramat® has existed as an owner-managed company for over 50 years and would like to maintain or expand the product range for cardiovascular surgery at the production site in Germany.
This has created a “win-win situation” for both companies, as Santec can benefit from Atramat®‘s international contacts while Atramat® complement their existing general surgical suture portfolio with cardiac surgery products and implants from Santec.
In addition, Santec, as a long-standing German manufacturer, offers Atramat® access to German-speaking countries with its own CE approvals. Joint sales activities will be coordinated in 2020 and the know-how on both sides will be used to win new customers and/or convince existing customers of new products from Atramat® and Santec.
Santec Medicalprodukte GmbH
Detlev-Sven Neumann, CEO